Cormedix inc. (CRMD)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue
Net sales

74

24

59

35

163

26

372

7

23

92

61

136

39

121

44

16

41

22

35

119

31

84

52

39

12

2

0

0

0

-

-

-

-

-

-

-

-

-

-

Cost of sales

48

46

79

21

226

22

312

33

28

-63

66

18

93

85

43

187

50

-164

-35

-101

-17

-273

-36

-54

-81

-201

0

0

0

-

-

-

-

-

-

-

-

-

-

Gross profit (loss)

25

-21

-19

14

-63

4

60

-26

-5

155

-5

118

-54

36

0

-170

-8

-141

0

18

13

-188

15

-14

-68

-199

0

0

0

-

-

-

-

-

-

-

-

-

-

Operating Expenses
Research and development

2,472

2,677

2,520

2,979

2,874

-4,347

8,289

6,600

8,280

8,457

6,014

5,089

4,924

4,032

6,840

2,772

2,089

1,485

1,764

1,797

1,234

501

292

171

353

-159

750

380

255

297

244

236

363

-424

1,724

1,582

1,175

760

560

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

746

376

536

539

877

898

834

642

617

Selling, general and administrative

3,165

2,677

2,631

2,571

1,984

2,213

2,012

1,945

1,903

-

1,992

2,051

2,640

-

2,318

1,968

2,050

-

2,948

2,355

2,693

-

1,586

1,703

2,512

-

504

908

551

-

-

-

-

-

-

-

-

-

-

Total operating expenses

5,637

5,354

5,152

5,551

4,859

-2,133

10,301

8,546

10,183

10,426

8,006

7,140

7,564

6,578

9,158

4,741

4,139

3,751

4,713

4,152

3,927

2,025

1,879

1,874

2,865

1,364

1,255

1,288

806

495

991

613

899

114

2,601

2,480

2,010

1,402

1,178

Loss From Operations

-5,611

-5,375

-5,171

-5,537

-4,923

2,138

-10,241

-8,572

-10,188

-10,270

-8,011

-7,022

-7,619

-6,542

-9,157

-4,912

-4,148

-3,893

-4,712

-4,134

-3,913

-2,214

-1,863

-1,889

-2,934

-1,564

-1,255

-1,288

-806

-495

-991

-613

-899

-114

-2,601

-2,480

-2,010

-1,402

-1,178

Other Income (Expense)
Interest income

63

75

92

95

58

6

5

10

14

21

37

28

23

32

32

29

31

26

25

8

0

0

0

0

0

0

0

0

0

0

0

0

0

1

2

3

5

10

5

Foreign exchange transaction loss

-3

2

-12

-8

-1

4

-0

5

-9

-2

-4

-5

-1

-2

-1

-4

-0

-1

0

-5

-0

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

Loss on issuance of preferred stock, convertible notes and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

Value of warrants issued in connection with backstop financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,583

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange transaction gain (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-122

-20

-7

-4

1

-0

0

0

0

0

0

-

-

-

-

-

-

Loss on issuance of preferred stock, convertible notes and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

89

-

945

0

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-1,974

1,853

-

-

0

0

-

-

-

-

-

0

-586

5,419

-13,681

-409

45

0

0

-

0

-

-

-

-

-

-

-

-

Loss on modification of equity instruments and extinguishment of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,462

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

Loss on modification of equity instruments and extinguishment of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-33

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

6

6

172

306

302

0

0

0

1

2

2

0

0

0

0

0

0

-2

1

3

0

0

0

0

0

30

312

661

440

356

26

0

0

-

0

-

-

-

0

Total other income (expense)

-

-

-93

-219

-

10

5

15

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss Before Income Taxes

-

-

-5,264

-5,756

-

-

-10,236

-8,556

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

54

-

-

-

-244

-

-

-

-

-39

-1,944

1,876

22

-

31

25

30

-

24

-0

-1,583

-

-3,171

-

-

-

-

-

-

-

-

-

-

-

0

0

29

-

-

LOSS BEFORE INCOME TAXES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,247

-851

-1,016

-612

-898

-113

-2,599

-2,477

-1,975

-1,392

-1,172

Tax benefit

-

-

-

-5,060

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

0

-

-

-

0

Net Loss

-5,557

-5,304

-5,264

-696

-5,167

2,148

-10,236

-8,556

-10,185

-10,310

-9,956

-5,146

-7,596

-6,512

-9,126

-4,886

-4,118

-3,866

-4,688

-4,135

-5,497

-2,214

-5,035

3,509

-16,713

-3,435

-2,499

-1,950

-1,247

-851

-1,016

-612

-898

380

-2,599

-2,477

-1,975

-1,392

-1,172

Other Comprehensive Loss
Unrealized loss from investment

-5

-4

-3

8

-1

-

-

0

0

0

2

0

10

-6

-6

24

-0

-24

5

-5

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation loss

-0

-0

0

0

-0

5

-6

0

-1

-

-4

6

-0

-

-0

-27

31

-

1

-3

2

-

118

-9

1

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Total other comprehensive loss

-6

-4

-2

9

-1

5

-6

0

-1

-

-1

6

9

-

-6

-2

30

-

7

-9

2

-

118

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive Loss

-5,564

-5,308

-5,267

-687

-5,169

2,154

-10,242

-8,556

-10,186

-10,306

-9,958

-5,139

-7,587

-6,514

-9,133

-4,889

-4,087

-3,903

-4,681

-4,144

-5,494

-2,232

-4,916

3,518

-16,714

-3,444

-2,499

-1,950

-1,247

-

-

-

-

-

-

-

-

-

-

Net Loss

-5,557

-5,304

-5,264

-696

-5,167

2,148

-10,236

-8,556

-10,185

-10,310

-9,956

-5,146

-7,596

-6,512

-9,126

-4,886

-4,118

-3,866

-4,688

-4,135

-5,497

-2,214

-5,035

3,509

-16,713

-3,435

-2,499

-1,950

-1,247

-851

-1,016

-612

-898

380

-2,599

-2,477

-1,975

-1,392

-1,172

Deemed dividend as a result of warrant modification

-

-

-369

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend as a result of exchange of convertible note and Series C-2, Series D and Series F preferred stock, related party

-

-

-26,733

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss Attributable to Common Shareholders

-

-

-32,367

-

-

-

-10,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dividends, including deemed dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-33

-

-27

-27

-27

-

-53

0

-309

-

0

-

0

-

-

-

-

-

-

Deemed dividend - beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Net Loss Attributable To Common Shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,688

-4,135

-5,530

-

-5,062

3,481

-16,740

-

-2,553

-1,950

-1,556

-

-1,016

-612

-898

-

-

-

-

-

-

Net Loss Per Common Share – Basic and Diluted (in Dollars per share)

-0.21

-0.20

-1.35

-0.03

-0.22

0.23

-0.54

-0.52

-0.68

-0.14

-0.17

-0.10

-0.19

-0.18

-0.23

-0.13

-0.11

-0.08

-0.14

-0.13

-0.23

-

-0.23

-

-0.87

-

-0.18

-

-0.13

-0.08

-0.09

-0.05

-0.08

0.04

-0.23

-0.22

-0.17

-0.12

-0.10

Weighted Average Common Shares Outstanding – Basic and Diluted (in Shares)

26,059

25,692

24,015

23,825

23,074

20,893

18,831

16,470

15,071

67,065

60,290

52,583

40,624

40,355

39,053

36,447

36,012

35,243

34,585

31,623

23,921

-

22,080

-

19,264

-

14,430

-

11,603

11,408

11,408

11,408

11,408

-

11,408

11,408

-

-

-

Net Loss Per Common Share - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.12

-

-

-

-0.15

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Common Shares Outstanding - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,993

-

-

-

13,048

-

-

-

-

-

-

-

-

-

-

-

Net Loss Per Common Share - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.05

-

-

-

-0.15

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Common Shares Outstanding - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,439

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Common Shares Outstanding - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,048

-

-

-

-

-

-

-

-

-

-

-

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,408

11,408

11,408